-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).
-
Summary
-
Northwest Biotherapeutics Inc quarterly/annual Revenues history and growth rate from 2017 to 2023.
- Northwest Biotherapeutics Inc Revenues for the quarter ending March 31, 2024 was $284K, a 67.7% decline year-over-year.
- Northwest Biotherapeutics Inc Revenues for the twelve months ending March 31, 2024 was $1.34M, a 38.1% decline year-over-year.
- Northwest Biotherapeutics Inc annual Revenues for 2023 was $1.93M, a 14.8% increase from 2022.
- Northwest Biotherapeutics Inc annual Revenues for 2022 was $1.68M, a 67.5% increase from 2021.
- Northwest Biotherapeutics Inc annual Revenues for 2021 was $1.01M, a 22.2% decline from 2020.